Elan Announces Filing of Annual Report on Form 20-F for Year Ended December
DUBLIN -- February 12, 2013
Elan Corporation, plc (NYSE: ELN) today announced the filing of its Annual
Report on Form 20-F for the fiscal year ended December 31, 2012. The Form 20-F
is available on Elan's website at http://www.elan.com. Elan will provide to
all holders of Elan securities, upon request and free of charge, a hard copy
of our complete audited financial statements included in our Form 20-F.
About Elan Corporation, plc
Elan Corporation, plc is a biotechnology company, headquartered in Ireland,
committed to making a difference in the lives of patients and their families
by dedicating itself to bringing innovations in science to fill significant
unmet medical needs that continue to exist around the world. Elan shares trade
on the New York and Irish Stock Exchanges. For additional information about
the Elan, please visit http://www.elan.com.
Chris Burns, 800-252-3526
David Marshall, 353-1-709-4444
Emer Reynolds, + 353-1-709-4022
Jonathan Birt, +44-751-559-7858
Press spacebar to pause and continue. Press esc to stop.